Bloom Energy’s Valuation Debate Intensifies Amid AI Infrastructure Surge

Bloom Energy US0937121079

Shares of Bloom Energy have soared to near-record levels following the announcement of a landmark partnership with Brookfield Asset Management, creating a sharp divide among market participants over the company's valuation. While some investors are captivated by its role in powering artificial intelligence infrastructure, others point to extreme valuation metrics as a cause for concern.

A pivotal development occurred in October 2025, when Bloom Energy unveiled a strategic alliance with Brookfield Asset Management. The agreement involves a planned $5 billion investment into Bloom's fuel cell technology. Under the terms, Bloom becomes the preferred energy partner for Brookfield's global portfolio of AI data centers.

Key aspects of the partnership include:

• Addressing AI Power Demand: The collaboration specifically targets the enormous electricity requirements of AI infrastructure using Bloom's fuel cell solutions.
• Grid-Independent Power: This technology offers a path to bypass increasingly congested public power grids.
• European Expansion: A new AI site in Europe is slated for announcement before the end of the current year.
• Strategic Capital: The investment represents the first deployment from Brookfield's dedicated AI infrastructure strategy.

Institutional Investors Take Divergent Paths

The valuation debate is reflected in the contrasting moves of major institutional investors. Norway's sovereign wealth fund, Norges Bank, established a new position comprising 2.4 million shares, valued at approximately $57.8 million, representing about 1.03% of outstanding shares. Conversely, Bosun Asset Management significantly reduced its exposure during the second quarter, selling 84,820 shares—a 71.4% cut to its holding.

These opposing actions underscore the lack of consensus on the stock's current price level. Collectively, institutional investors hold roughly 77% of Bloom Energy's shares.

Sky-High Multiples Draw Scrutiny

With a market capitalization hovering around $28 billion against trailing twelve-month revenue of $1.82 billion, the company's financial ratios have entered remarkable territory:

• Price-to-Earnings (P/E) Ratio: Exceeds 1,400 based on trailing earnings.
• Price-to-Sales Ratio: Approximately 15.
• Gross Margin: Below 30%.
• Net Profit Margin: Under 1%.

Further highlighting the market's speculative fervor, Bloom recently placed $2.2 billion in zero-coupon convertible notes. The conversion price was set near $195 per share, representing a 52.5% premium to the closing price on October 30.

Analyst Opinions Remain Sharply Divided

The analyst community mirrors the broader market's split. The consensus recommendation currently stands at "Hold," with an average price target of $93.77—about 21% below recent trading levels. Targets vary wildly, from a low of $39 (Bank of America Securities) to a high of $157 (Susquehanna). Out of 25 covering analysts, roughly 10 advocate buying the shares, 12 recommend holding, and 3 advise selling.

Outlook: Elevated Volatility Expected to Continue

Bloom's operational performance has been strong. Third-quarter 2025 results significantly exceeded expectations, with revenue reaching $519 million—a 57% year-over-year increase—and earnings per share of $0.15 against forecasts of $0.08. Management has reaffirmed that it will surpass its original annual targets.

Despite this fundamental strength, share price volatility remains exceptionally high. The stock's beta of 3.0 indicates it typically moves three times as much as the broader market. This was evident in November alone, when the share price fell 17.3% before recovering in early December.